This post was originally published on this site.
Nike has named Pfizer CFO David M. Denton as Executive Vice President and Chief Financial Officer, effective 17 August, as the brand enters a new phase in its turnaround.
In August, he will replace Matthew Friend, who is currently in the role and will stay with the company through 4 September to help with an orderly transition.
Nike said Denton will head its global finance organisation and work with President and CEO Elliott Hill and the senior leadership team to support disciplined execution, capital allocation and long-term value creation.
Hill noted Denton’s “experience, judgment, and operating rigor” as key qualities that will help the company execute against these key priorities.
“This is a natural moment for a leadership transition as we move from foundational actions to sustained growth through our Sport Offense operating model,” Hill said.
Denton has more than 30 years of finance and operating leadership experience across global public companies. He has been CFO and Executive Vice President at Pfizer since May 2022 and, before that, held CFO posts at Lowe’s Companies, a retailer focused on home improvement and hardware, and CVS Health, where he spent about two decades. From 2014 to 2023, he also served on the board of fashion group Tapestry, parent company of Coach and Kate Spade.
“Nike is one of the world’s great brands, with extraordinary strengths in sport, innovation, and global scale,” said Denton.
“I’m excited to partner with Elliott and the leadership team to support the company’s priorities, invest with discipline, and help deliver sustainable long-term value as Nike continues to lead with sport and serve athletes around the world.”
The appointment comes as Nike continues to reshape its leadership under Hill.
In December 2025, the company reorganised its senior leadership team, creating a Chief Operating Officer role, eliminating the Chief Technology Officer and Chief Commercial Officer positions, and adding four geography leaders to Hill’s direct reports. Nike said at the time that the changes were designed to remove layers and bring the company closer to athletes and the marketplace.
Nike’s fiscal fourth-quarter results are scheduled for 30 June. Shares rose 2% in after-hours trading on 23 June following the CFO announcement.
Nike is not the only sportswear giant that has been re-shaping its senior leadership team.
Over the last few months, competitor Puma has embarked on a hiring spree, appointing former Nike and Adidas Alumni as it looks to establish itself as a top-three global sports brand.
It has hired former Nike and ASICS alumni Bertrand Blanc as Vice President of Global Wholesale, former Vice President of Originals, Basketball & Partnerships Europe at Adidas, Laurent Fricker, to lead its Sportstyle Business Unit and former Adidas VP of Global Brand Strategy, James Carnes to lead its new creative direction.
Nike is also facing intensifying competition from Adidas, which reported a 14% increase in currency-neutral revenues for the first quarter of 2026, leading to net sales of €6.6 billion (£5.7 billion).
This builds on the “record-breaking” revenues Adidas reported for its full-year results for 2025, which were published in March. It showed a 5% increase in revenues to €24.8 billion, with double-digit growth across all markets and channels.
![[Aggregator] Downloaded image for imported item #43114 Nike appoints Pfizer CFO as turnaround enters next phase](https://digitalsourcenews.com/wp-content/uploads/2026/06/260620_DaveDenton_0025_cropped-150x150-1.jpg)